Patents by Inventor Darren Mark Platt

Darren Mark Platt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040161827
    Abstract: A family of p53 tumor suppressor nucleic acid and protein isolated from several insect species is described. The p53 nucleic acid and protein can be used to genetically modify metazoan invertebrate organisms, such as insects and worms, or cultured cells, resulting in p53 expression or mis-expression. The genetically modified organisms or cells can be used in screening assays to identify candidate compounds that are potential pesticidal agents or therapeutics that interact with p53 protein. They can also be used in methods for studying p53 activity and identifying other genes that modulate the function of, or interact with, the p53 gene. Nucleic acid and protein sequences for Drosophila p33 and Rb tumor suppressors are also described.
    Type: Application
    Filed: February 5, 2004
    Publication date: August 19, 2004
    Inventors: Andrew Roy Buchman, Darren Mark Platt, Michael Martin Ollmann, Lynn Marie Young, Madelyn Robin Demsky, Kevin Patrick Keegan, Lori Friedman, Casey Kopczynski, Jeffrey S. Larson, Stephanie A. Robertson
  • Patent number: 6762291
    Abstract: A family of p53 tumor suppressor nucleic acid and protein isolated from several insect species is described. The p53 nucleic acid and protein can be used to genetically modify metazoan invertebrate organisms, such as insects and worms, or cultured cells, resulting in p53 expression or mis-expression. The genetically modified organisms or cells can be used in screening assays to identify candidate compounds that are potential pesticidal agents or therapeutics that interact with p53 protein. They can also be used in methods for studying p53 activity and identifying other genes that modulate the function of, or interact with, the p53 gene. Nucleic acid and protein sequences for Drosophila p33 and Rb tumor suppressors are also described.
    Type: Grant
    Filed: March 13, 2000
    Date of Patent: July 13, 2004
    Assignee: Exelixis, Inc.
    Inventors: Andrew Roy Buchman, Darren Mark Platt, Michael Martin Ollman, Lynn Marie Young, Madelyn Robin Demsky, Kevin Patrick Keegan, Lori Friedman, Casey Kopczynski, Jeffrey S. Larson, Stephanie A. Robertson
  • Publication number: 20030187246
    Abstract: The present invention relates to C. elegans insulin-like genes and methods for identifying insulin-like genes. The methods provide nucleotide sequences of C. elegans insulin-like genes, amino acid sequences of their encoded proteins, and derivatives (e.g., fragments) and analogs thereof. The invention further relates to fragments (and derivatives and analogs thereof) of insulin-like proteins which comprise one or more domains of an insulin-like protein. Antibodies to an insulin-like protein, and derivatives and analogs thereof, are provided. Methods of production of an insulin-like protein (e.g., by recombinant means), and derivatives and analogs thereof, are provided. Further, methods to identify the biological function of a C. elegans insulin-like gene are provided, including various methods for the functional modification (e.g., overexpression, underexpression, mutation, knock-out) of one or more genes simultaneously. Still further, methods to identify a C.
    Type: Application
    Filed: January 9, 2003
    Publication date: October 2, 2003
    Inventors: Stephen Kohl Doberstein, Andrew Roy Buchman, Kimberly Carr Ferguson, Sheila Akiko Homburger, Darren Mark Platt
  • Patent number: 6627746
    Abstract: The present invention relates to C. elegans insulin-like genes and methods for identifying insulin-like genes. The methods provide nucleotide sequences of C. elegans insulin-like genes, amino acid sequences of their encoded proteins, and derivatives (e.g., fragments) and analogs thereof. The invention further relates to fragments (and derivatives and analogs thereof) of insulin-like proteins which comprise one or more domains of an insulin-like protein. Antibodies to an insulin-like protein, and derivatives and analogs thereof, are provided. Methods of production of an insulin-like protein (e.g., by recombinant means), and derivatives and analogs thereof, are provided. Further, methods to identify the biological function of a C. elegans insulin-like gene are provided, including various methods for the functional modification (e.g., overexpression, underexpression, mutation, knock-out) of one or more genes simultaneously. Still further, methods to identify a C.
    Type: Grant
    Filed: May 26, 1998
    Date of Patent: September 30, 2003
    Assignee: Exelixis, Inc.
    Inventors: Stephen Kohl Doberstein, Darren Mark Platt, Kimberly Carr Ferguson, Andrew Roy Buchman, Sheila Akiko Homburger
  • Patent number: 6511824
    Abstract: Tandem pore domain weak inward rectifying K+ (TWIK) channel nucleic acids and proteins that have been isolated from Drosophila melanogaster and Leptinotarsa are described. The TWIK channel nucleic acids and proteins can be used to genetically modify metazoan invertebrate organisms, such as insects, coelomates, and pseudocoelomates, or cultured cells, resulting in TWIK channel expression or mis-expression. The genetically modified organisms or cells can be used in screening assays to identify candidate compounds which are potential pesticidal agents or therapeutics that interact with TWIK channel proteins. They can also be used in methods for studying TWIK channel activity and identifying other genes that modulate the function of, or interact with, the TWIK channel gene.
    Type: Grant
    Filed: July 28, 1999
    Date of Patent: January 28, 2003
    Assignee: Exelixis, Inc.
    Inventors: Andrew Roy Buchman, Christian Burks, Helen Louise Francis-Lang, Lucile A. Gillett, Jonathan Cagampang Heller, Casey Casimir Kopczynski, Jonathan Scott Margolis, Darren Mark Platt, Bindu Priya Reddy, Candace Swimmer, John W. Winslow, Yuling Luo